Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2022-04-11 00:00:00 ET · period of report 2022-04-07 · accession 0001209191-22-024064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-11 | 2022-04-07 | ACAD | Kihara James | Principal Accounting Off | M - OptEx | — | +2,977 | 3,458 | +619% | — |
| D | 2022-04-11 | 2022-04-08 | ACAD | Kihara James | Principal Accounting Off | S - Sale+OE | $27.05 | -1,025 | 2,433 | -30% | -$27.7K |
| D | 2022-04-11 | 2022-04-07 | ACAD | Kihara James | Principal Accounting Off | M - OptEx | $0.00 | -2,977 | 2,978 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | M | A | 2,977 | — | 3,458 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. |
| 2 | Common | Common Stock | 2022-04-08 | S | D | 1,025 | $27.05 | 2,433 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-04-07 | M | D | 2,977 | $0.00 | 2,978 | D | — · — to — | 2,977 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. (F3) 50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024. |